Sahar Ragab Mohamed El hadad
Genetic Engineering and Bioinformatics Research Center Manager · VACSERA
Research Interests
Immunology
Education
1997-07 - 2010-01 Ph.D: Immunology and Molecular biology Cairo University. * Professional development completed in Immunology and Molecular Biology Ph.D 1986-01 - 1991-01 Master of Science: Cell biology and Histochemistry Medical Research Institute, Alexandria University - Alexandria, Egypt • Professional development completed in Oral cancer Cell Biology and histochemistry project 1981-09 - 1985-07 Bachelor of Science Degree: Zoology and Chemistry Ain Shams University - Cairo, Egypt
Recent Scopus Publications
- The development of a novel oral 5-Fluorouracil in-situ gelling nanosuspension to potentiate the anticancer activity against colorectal cancer cells
- In vitro optimization, characterization and anti-tumor evaluation against colorectal cancer of a novel 5-fluorouracil oral nanosuspension using soy protein, polysaccharides-protein complexation, and in-situ gel formation
- Sustaining exposure to high concentrations of bifidobacteria inhibits gene expression of Mouse's mucosal immunity
- Publisher Correction: In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products (Scientific Reports, (2018), 8, 1, (12553), 10.1038/s41598-018-31006-3)
- Lactobacillus rhamnosus enhances the immunological antitumor effect of 5-fluorouracil against colon cancer
Research Outputs
1- Patent number: 11285104, Title: ORAL ADMINISTRATION OF 5-FU IN A GELLING NANOSUSPENSION FOR TARGETED DELIVERY TO TREAT COLORECTAL CANCERS Type: Grant Filed: May 21, 2021 Date of Patent: March 29, 2022 Assignee: KING ABDULAZIZ UNIVERSITY...
Links
- ORCID https://orcid.org/orcid.org
- Scopus https://www.scopus.com/authid/detail.uri?authorId=55620444900